Literature DB >> 28515938

Accounting for adjuvant-induced artifacts in the characterization of vaccine formulations by polyacrylamide gel electrophoresis.

Virginie Jakob1, Livia Brunner1, Christophe Barnier-Quer1, Molly Blust2, Nicolas Collin1, Lauren Carter2, Darrick Carter3, Kelly M Rausch4, Christopher B Fox5.   

Abstract

OBJECTIVES: Several vaccine adjuvants comprise complex nano- or micro-particle formulations, such as oil-in-water emulsions. In order to characterize interactions and compatibility of oil-in-water emulsion adjuvants with protein antigens in vaccines, effective protein characterization methods that can accommodate potential interference from high concentrations of lipid-based particles are needed.
METHODS: Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a standard protein characterization technique which is affected by the presence of adjuvants such as oil-in-water emulsions. In this article, we investigate variations in SDS-PAGE methods that result in a reduction of adjuvant-induced staining artifacts. We have investigated whether the SDS method or the adjuvant composition were the reason for these artifacts and succeeded in reducing the artifacts with a modified sample preparation and different staining procedures.
RESULTS: The best results were obtained by using gold staining or silver staining instead of a Coomassie Blue staining procedure. Moreover, the replacement of the dilution buffer (20% SDS to disrupt emulsion) by alternative detergents such as Tween® 80 and Triton® X-100 removed adjuvant-induced streaking artifacts at the top of the gel.
CONCLUSIONS: These methods may be useful for improving characterization approaches of antigen-adjuvant mixtures by SDS-PAGE.

Entities:  

Keywords:  oil-in-water emulsion; polyacrylamide gel electrophoresis; vaccine adjuvant characterization; vaccine adjuvant formulation

Year:  2017        PMID: 28515938      PMCID: PMC5418890          DOI: 10.1177/2051013617702072

Source DB:  PubMed          Journal:  Ther Adv Vaccines        ISSN: 2051-0136


  13 in total

Review 1.  Role of adjuvants in modeling the immune response.

Authors:  Darrick Carter; Steven G Reed
Journal:  Curr Opin HIV AIDS       Date:  2010-09       Impact factor: 4.283

Review 2.  An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.

Authors:  Christopher B Fox; Jean Haensler
Journal:  Expert Rev Vaccines       Date:  2013-07       Impact factor: 5.217

3.  Are we entering a new age for human vaccine adjuvants?

Authors:  Derek T O'Hagan; Christopher B Fox
Journal:  Expert Rev Vaccines       Date:  2015-05-06       Impact factor: 5.217

4.  The development of self-emulsifying oil-in-water emulsion adjuvant and an evaluation of the impact of droplet size on performance.

Authors:  Ruchi R Shah; Stephanie Dodd; Mary Schaefer; Mildred Ugozzoli; Manmohan Singh; Gillis R Otten; Mansoor M Amiji; Derek T O'Hagan; Luis A Brito
Journal:  J Pharm Sci       Date:  2015-01-19       Impact factor: 3.534

5.  Staining and Transfer Techniques for SDS-PAGE Gels to Minimize Oil-in-Water Emulsion Adjuvant Interference.

Authors:  Alicia M Schwartz; Michelle Y Chan; Dawn M Fedor; Sandra J Sivananthan; Ryan M Kramer
Journal:  Methods Mol Biol       Date:  2017

6.  Elimination of the cold-chain dependence of a nanoemulsion adjuvanted vaccine against tuberculosis by lyophilization.

Authors:  Mark T Orr; Ryan M Kramer; Lucien Barnes; Quinton M Dowling; Anthony L Desbien; Elyse A Beebe; John D Laurance; Christopher B Fox; Steven G Reed; Rhea N Coler; Thomas S Vedvick
Journal:  J Control Release       Date:  2013-12-29       Impact factor: 9.776

7.  A defined tuberculosis vaccine candidate boosts BCG and protects against multidrug-resistant Mycobacterium tuberculosis.

Authors:  Sylvie Bertholet; Gregory C Ireton; Diane J Ordway; Hillarie Plessner Windish; Samuel O Pine; Maria Kahn; Tony Phan; Ian M Orme; Thomas S Vedvick; Susan L Baldwin; Rhea N Coler; Steven G Reed
Journal:  Sci Transl Med       Date:  2010-10-13       Impact factor: 17.956

8.  Conjugating influenza a (H1N1) antigen to n-trimethylaminoethylmethacrylate chitosan nanoparticles improves the immunogenicity of the antigen after nasal administration.

Authors:  Qingfeng Liu; Xiaoyao Zheng; Chi Zhang; Xiayan Shao; Xi Zhang; Qizhi Zhang; Xinguo Jiang
Journal:  J Med Virol       Date:  2015-05-20       Impact factor: 2.327

9.  Silver staining of proteins in polyacrylamide gels.

Authors:  Mireille Chevallet; Sylvie Luche; Thierry Rabilloud
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

10.  Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.

Authors:  Mark T Orr; Christopher B Fox; Susan L Baldwin; Sandra J Sivananthan; Elyse Lucas; Susan Lin; Tony Phan; James J Moon; Thomas S Vedvick; Steven G Reed; Rhea N Coler
Journal:  J Control Release       Date:  2013-08-09       Impact factor: 9.776

View more
  1 in total

1.  O/W Nanoemulsion as an Adjuvant for an Inactivated H3N2 Influenza Vaccine: Based on Particle Properties and Mode of Carrying.

Authors:  Lanhua Zhao; Zhe Zhu; Lei Ma; Yingbo Li
Journal:  Int J Nanomedicine       Date:  2020-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.